Director, Global R&D Bioassay and Microbiology
Pfizer
Lake Forest, Illinois, United States
Immunogenicity Risk Assessment: Are Preclinical Methods Informative? (S03)
Monday, November 18, 2024
9:00 AM – 12:00 PM CT
In Vitro Assay Methods for Pre-clinical Biosimilar and Generic Drug Product Evaluation (S03-2)
Monday, November 18, 2024
9:20 AM – 9:50 AM CT